|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn847649930 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
090330s2009 nyu ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCO
|d N$T
|d OCLCF
|d OCLCQ
|d OCLCO
|d YDXCP
|d OCLCQ
|d EBLCP
|d OCLCO
|d DEBSZ
|d OCLCQ
|d OCLCO
|d AZK
|d OCLCO
|d LOA
|d MOR
|d CCO
|d PIFAG
|d ZCU
|d MERUC
|d OCLCQ
|d U3W
|d STF
|d WRM
|d COCUF
|d NRAMU
|d ICG
|d VT2
|d OCLCO
|d WYU
|d OCLCQ
|d TKN
|d DKC
|d OCLCO
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 923657824
|a 961569319
|a 962707881
|
020 |
|
|
|a 9781608767267
|q (electronic bk.)
|
020 |
|
|
|a 1608767264
|q (electronic bk.)
|
020 |
|
|
|z 1607415933
|q (hardcover ;
|q alk. paper)
|
020 |
|
|
|z 9781607415930
|q (hardcover ;
|q alk. paper)
|
029 |
1 |
|
|a AU@
|b 000053300415
|
029 |
1 |
|
|a DEBBG
|b BV044087489
|
029 |
1 |
|
|a DEBSZ
|b 449537552
|
029 |
1 |
|
|a DEBSZ
|b 454916469
|
029 |
1 |
|
|a NZ1
|b 15345586
|
035 |
|
|
|a (OCoLC)847649930
|z (OCoLC)923657824
|z (OCoLC)961569319
|z (OCoLC)962707881
|
050 |
|
4 |
|a RC280.B8
|b L2715 2009eb
|
072 |
|
7 |
|a HEA
|x 039030
|2 bisacsh
|
082 |
0 |
4 |
|a 362.196/99449
|2 22
|
082 |
0 |
4 |
|a 362.196/99449
|2 23
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Lacroix, Marc,
|d 1963-
|
245 |
1 |
0 |
|a Molecular therapy of breast cancer :
|b classicism meets modernity /
|c Marc Lacroix.
|
260 |
|
|
|a New York :
|b Nova Biomedical Books,
|c ©2009.
|
300 |
|
|
|a 1 online resource (viii, 291 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Cancer etiology, diagnosis and treatments series
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a ""Molecular Therapy of Breast Cancer: Classicism Meets Modernity""; ""Dedication""; ""Contents ""; ""Preface""; ""Introduction ""; ""References ""; ""Selective Estrogen Receptor Modulators (SERMs) and Down-Regulators (SERDs)""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Selective Estrogen Receptor Modifiers (SERMs) ""; ""Tamoxifen ""; ""Toremifene ""; ""Fulvestrant ""; ""Conclusion ""; ""References ""; ""Aromatase Inhibitors ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Anastrozole ""; ""Letrozole ""; ""Exemestane ""
|
505 |
8 |
|
|a ""Conclusion """"References ""; ""Agents Inducing Ovarian Suppression ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Goserelin ""; ""Triptorelin""; ""Leuprolide ""; ""Conclusion ""; ""References ""; ""Antimetabolites ""; ""Abstract ""; ""Introduction""; ""Clinical Trials in January 2009 ""; ""Fluorouracil ""; ""Capecitabine ""; ""Gemcitabine ""; ""Pemetrexed ""; ""Methotrexate ""; ""Conclusion ""; ""References""; ""Alkylating Agents ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Cyclophosphamide ""
|
505 |
8 |
|
|a ""Platinum Compounds (Cisplatin, Carboplatin, Oxaliplatin, Picoplatin) -- Generalities """"Cisplatin ""; ""Carboplatin ""; ""Oxaliplatin ""; ""Picoplatin ""; ""Temozolomide ""; ""Thiotepa""; ""Ifosfamide ""; ""Melphalan ""; ""Busulfan ""; ""Conclusion ""; ""References ""; ""Anthracyclines ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Doxorubicin ""; ""Liposomal Doxorubicin ""; ""Epirubicin ""; ""Conclusion ""; ""References""; ""Microtubule-Binding Agents ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Taxanes -- Generalities ""
|
505 |
8 |
|
|a ""Larotaxel """"Docetaxel ""; ""Paclitaxel and Nab-Paclitaxel ""; ""Epothilones -- Generalities ""; ""Ixabepilone ""; ""Patupilone ""; ""Sagopilone ""; ""Vinca Alkaloids -- Generalities ""; ""Vinorelbine""; ""Vinflunine ""; ""Eribulin ""; ""Conclusion ""; ""References ""; ""Topoisomerase Inhibitors ""; ""Abstract ""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Irinotecan ""; ""Etoposide ""; ""Conclusion ""; ""References""; ""HER Family Inhibitors ""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Trastuzumab ""; ""Lapatinib ""; ""Gefitinib ""
|
505 |
8 |
|
|a ""Erlotinib """"Pertuzumab ""; ""Cetuximab ""; ""Ertumaxomab ""; ""Neratinib ""; ""Trastuzumab-MCC-DM1 ""; ""BIBW 2992 ""; ""ARRY-334543 ""; ""Conclusion ""; ""References ""; ""Angiogenesis Inhibitors ""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009 ""; ""Bevacizumab""; ""Sunitinib ""; ""Vandetanib ""; ""Pazopanib ""; ""Ramucirumab ""; ""ABT-869 ""; ""AV-951 ""; ""PTC299""; ""AMG 386 ""; ""Aflibercept ""; ""Conclusion""; ""References ""; ""Insulin-Like Growth Factor-I Receptor (IGF-1R) Inhibitors""; ""Abstract""; ""Introduction ""; ""Clinical Trials in January 2009""
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Breast
|x Cancer
|x Molecular aspects.
|
650 |
|
0 |
|a Antineoplastic agents.
|
650 |
|
0 |
|a Antimitotic agents.
|
650 |
1 |
2 |
|a Breast Neoplasms
|x drug therapy
|
650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use
|
650 |
2 |
2 |
|a Enzyme Inhibitors
|x therapeutic use
|
650 |
|
2 |
|a Antineoplastic Agents
|
650 |
|
2 |
|a Antimitotic Agents
|
650 |
|
6 |
|a Sein
|x Cancer
|x Aspect moléculaire.
|
650 |
|
6 |
|a Anticancéreux.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x Cancer.
|2 bisacsh
|
650 |
|
7 |
|a Antimitotic agents
|2 fast
|
650 |
|
7 |
|a Antineoplastic agents
|2 fast
|
650 |
|
7 |
|a Breast
|x Cancer
|x Molecular aspects
|2 fast
|
758 |
|
|
|i has work:
|a Molecular therapy of breast cancer (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCG9XwgDvmYBgTdpFMgH8cq
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|a Lacroix, Marc, 1963-
|t Molecular therapy of breast cancer.
|d New York : Nova Biomedical Books, ©2009
|w (DLC) 2009013524
|
830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3018284
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3018284
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10660145
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 311198
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 10225855
|
994 |
|
|
|a 92
|b IZTAP
|